Mga Batayang Estadistika
| CIK | 768408 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cyanotech Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| September 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 29, 2025 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| September 2, 2025 |
FIFTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE Exhibit 10.1 FIFTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE This FIFTH AMENDMENT (this “Amendment”) to the Amended and Restated Promissory Note (the “Note”), by and between Skywords Family Foundation Inc. (“Lender”) and Cyanotech Corporation, a Nevada Corporation (“Borrower”), dated as of April 12, 2021, as amended on December 14, 2022, August 14, 2023, August 9, 2024 and May 2, 2025 is e |
|
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 21, 2025 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2025 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH |
|
| August 6, 2025 |
Press Release dated August 6, 2025 Exhibit 99.1 News Release Contact: Jennifer Rogerson (808) 334-9455 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal 2026 KAILUA KONA, Hawaii (August 6, 2025) — Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of f |
|
| August 6, 2025 |
Amendment No. 1 to the Cyanotech Corporation 2016 Equity Incentive Plan Exhibit 10.1 AMENDMENT NO. 1 TO THE CYANOTECH CORPORATION 2016 EQUITY INCENTIVE PLAN This Amendment No. 1 (the “Amendment”) to the Cyanotech Corporation 2016 Equity Incentive Plan (the “Plan”) is made effective as of May 30, 2025, by Cyanotech Corporation, a Nevada corporation (the “Company”). The Amendment was approved by the Compensation and Stock Option Committee of the Board of Directors of th |
|
| July 10, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| June 20, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2025 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH CO |
|
| June 20, 2025 |
Press Release dated June 20, 2025. Exhibit 99.1 News Release Contact: Jennifer Rogerson (808) 334-9455 [email protected] Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025 KAILUA KONA, Hawaii (June 20, 2025) — Cyanotech Corporation (OTCQB Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourt |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2025 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 91-12 |
|
| May 8, 2025 |
Exhibit 10.1 FOURTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE This FOURTH AMENDMENT (this “Amendment”) to the Amended and Restated Promissory Note (the “Note”), by and between Skywords Family Foundation Inc. (“Lender”) and Cyanotech Corporation, a Nevada Corporation (“Borrower”), dated as of April 12, 2021, as amended on December 14, 2022, August 14, 2023 and August 9, 2024, is entered int |
|
| May 8, 2025 |
Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the “Agreement”) is entered into as of May 7, 2025 (the “Effective Date”) by and between Matthew Custer (“Executive”) and Cyanotech Corporation (the “Company”). Upon the Effective Date, this Agreement shall supersede and replace that certain Executive Employment Agreement, dated as of June 16, 2022, between Executive |
|
| February 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOT |
|
| February 11, 2025 |
Press Release dated February 11, 2025 Exhibit 99.1 News Release Contact: Jennifer Rogerson (808) 334-9455 [email protected] Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2025 KAILUA KONA, Hawaii (February 11, 2025) — Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results f |
|
| December 16, 2024 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 10, 2024 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) |
|
| December 16, 2024 |
Letter from Grant Thornton LLP to the Securities and Exchange Commission dated December 16, 2024 Exhibit 16.1 December 16, 2024 U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F Street, NE Washington, DC 20549 Re: Cyanotech Corporation File No. 000-14602 Dear Sir or Madam: We have read Item 4.01 of Form 8-K of Cyanotech Corporation dated December 16, 2024, and agree with the statements concerning our Firm contained therein. Very truly yours, /s/ GRANT THORNTON LLP |
|
| November 12, 2024 |
Press Release dated November 12, 2024 Exhibit 99.1 News Release Contact: Jennifer Rogerson (808) 334-9455 [email protected] Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2025 KAILUA KONA, Hawaii (November 12, 2024) — Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results f |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANO |
|
| October 3, 2024 |
CYAN / Cyanotech Corporation / DAVIS MICHAEL A / Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 13) Cyanotech Corporation (Name of Issuer) Common Stock, $0.02 par value per share (Title of Class of Securities) 232437301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane Tiburon, CA 94920 (Name, Address and Telephone Number of Person Authorized to Receiv |
|
| September 12, 2024 |
CYAN / Cyanotech Corporation / DAVIS MICHAEL A / Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 12) Cyanotech Corporation (Name of Issuer) Common Stock, $0.02 par value per share (Title of Class of Securities) 232437301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane Tiburon, CA 94920 (Name, Address and Telephone Number of Person Authorized to Receiv |
|
| September 6, 2024 |
CYAN / Cyanotech Corporation / DAVIS MICHAEL A / Activist Investment SC 13D/A 1 cyan13da11.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 11) Cyanotech Corporation (Name of Issuer) Common Stock, $0.02 par value per share (Title of Class of Securities) 232437301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane Tiburon, CA 94920 (Name, Address and Telephone Number of P |
|
| August 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 22, 2024 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 15, 2024 |
CYAN / Cyanotech Corporation / DAVIS MICHAEL A / Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 10) Cyanotech Corporation (Name of Issuer) Common Stock, $0.02 par value per share (Title of Class of Securities) 232437301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane Tiburon, CA 94920 (Name, Address and Telephone Number of Person Authorized to Receiv |
|
| August 13, 2024 |
Exhibit 10.1 THIRD AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE This THIRD AMENDMENT (this “Amendment”) to the Amended and Restated Promissory Note (the “Note”), by and between Skywords Family Foundation Inc. (“Lender”) and Cyanotech Corporation, a Nevada Corporation (“Borrower”), dated as of April 12, 2021, as amended on December 14, 2022 and August 14, 2023, is entered into as of August 9, |
|
| August 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 9, 2024 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 91 |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH |
|
| August 7, 2024 |
Press Release dated August 7, 2024 Exhibit 99.1 News Release Contact: Felicia Ladin (808) 334-9455 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal 2025 KAILUA KONA, Hawaii (August 7, 2024) — Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fisca |
|
| July 26, 2024 |
CYAN / Cyanotech Corporation / DAVIS MICHAEL A / Activist Investment SC 13D/A 1 cyan13da9.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9) Cyanotech Corporation (Name of Issuer) Common Stock, $0.02 par value per share (Title of Class of Securities) 232437301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane Tiburon, CA 94920 (Name, Address and Telephone Number of Per |
|
| July 11, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| June 28, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| June 26, 2024 |
Press Release dated June 26, 2024. Exhibit 99.1 News Release Contact: Felicia Ladin (808) 334-9455 [email protected] Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2024 KAILUA KONA, Hawaii (June 26, 2024) — Cyanotech Corporation (OTCQB Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth qu |
|
| June 26, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH CO |
|
| June 26, 2024 |
Insider Trading Policy (Adopted August 29, 2011, Updated Effective December 1, 2023) Exhibit 10.20 CYANOTECH CORPORATION Insider Trading Policy (Adopted August 29, 2011, Updated Effective December 1, 2023) Purpose This Insider Trading Policy (the “Policy”) provides guidelines with respect to transactions in the securities of Cyanotech Corporation (the “Company”) and the handling of confidential information about the Company, its subsidiaries and the companies with which the Compan |
|
| June 26, 2024 |
Clawback Policy (Effective October 2, 2023) Exhibit 10.21 Clawback Policy The Board of Directors (the “Board”) of Cyanotech Corporation and its subsidiary, Nutrex Hawaii, Inc. (the “Company”) believes that it is in the best interests of the Company and its shareholders to adopt this Clawback Policy (the “Policy”), which provides for the recovery of certain incentive compensation in the event of an Accounting Restatement (as defined below). |
|
| February 14, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 8, 2024 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) |
|
| February 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOT |
|
| February 8, 2024 |
Press Release dated February 8, 2024 Exhibit 99.1 News Release Contact: Felicia Ladin (808) 334-9455 [email protected] Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024 KAILUA KONA, Hawaii (February 8, 2024) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financia |
|
| December 20, 2023 |
CYAN / Cyanotech Corporation / DAVIS MICHAEL A / Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8) Cyanotech Corporation (Name of Issuer) Common Stock, $0.02 par value per share (Title of Class of Securities) 232437301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane Tiburon, CA 94920 (Name, Address and Telephone Number of Person Authorized to Receive |
|
| December 19, 2023 |
Exhibit 10.1 SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into as of December 15, 2023, by and among Cyanotech Corporation, a Nevada corporation (the “Company”) and each of the investors listed on Schedule 1 hereto (each, an “Investor” and collectively, the “Investors”). WHEREAS, the Company and the Investors desire to enter into a private placement of |
|
| December 19, 2023 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 15, 2023 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) |
|
| November 8, 2023 |
Press Release dated November 8, 2023 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024 KAILUA KONA, Hawaii (November 8, 2023) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANO |
|
| August 30, 2023 |
CYAN / Cyanotech Corp. / Ginungagap Foundation Activist Investment SC 13D/A 1 cyan13da-a1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Cyanotech Corporation (Name of Issuer) Common Stock, $0.02 par value per share (Title of Class of Securities) 232437301 (CUSIP Number) Mark Finser, Ginungagap Foundation 1621 Juanita Lane Tiburon, California 94920 (415) 699-999 |
|
| August 29, 2023 |
Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 24, 2023 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 29, 2023 |
CYAN / Cyanotech Corp. / DAVIS MICHAEL A / Activist Investment SC 13D/A 1 cyan13da.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7) Cyanotech Corporation (Name of Issuer) Common Stock, $0.02 par value per share (Title of Class of Securities) 232437301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane Tiburon, CA 94920 (Name, Address and Telephone Number of Pers |
|
| August 29, 2023 |
CYAN / Cyanotech Corp. / Ginungagap Foundation Activist Investment SC 13D 1 cyan13d.htm IMAGE OMITTED UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 IMAGE OMITTED [https://www.sec.gov/Archives/edgar/data/768408/000093583623000598/clipimage003.gif] SCHEDULE 13D (Rule 13d-101) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* IMAGE OMITTED [https://www.sec.gov/Archives/edgar/data/768408/000093583623000598/clipimage003.gif] Cyanotech |
|
| August 17, 2023 |
Exhibit 10.1 SECOND AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE This SECOND AMENDMENT (this “Amendment”) to the Amended and Restated Promissory Note (the “Note”), by and between Skywords Family Foundation Inc. (“Lender”), and Cyanotech Corporation, a Nevada Corporation (“Borrower”), dated as of April 12, 2021, as amended on December 14, 2022, is entered into as of August 14, 2023. Except as |
|
| August 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 14, 2023 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 11, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 10, 2023 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH |
|
| August 11, 2023 |
Press Release dated August 11, 2023 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024 KAILUA KONA, Hawaii (August 11, 2023) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter |
|
| July 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defini |
|
| July 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 30, 2023 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 91- |
|
| June 27, 2023 |
Press Release dated June 27, 2023. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023 KAILUA KONA, Hawaii (June 27, 2023) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth qu |
|
| June 27, 2023 |
Exhibit 4.2 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The authorized capital stock of the Cyanotech Corporation consists of 50,000,000 shares of common stock, $0.02 par value per share (“Common Stock”) and 10,000,000 shares of Preferred Stock, $0.01 par value per share (“Preferred Stock”). Subject to the rights of holders of |
|
| June 27, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2023 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH CO |
|
| June 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 15, 2023 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 91- |
|
| May 8, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2023 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 91-12 |
|
| February 9, 2023 |
Press Release dated February 9, 2023 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2023 KAILUA KONA, Hawaii (February 9, 2023) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results |
|
| February 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2022 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOT |
|
| December 19, 2022 |
Exhibit 10.1 FIRST AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE This FIRST AMENDMENT (this ?Amendment?) to the Amended and Restated Promissory Note (the ?Note?), by and between Skywords Family Foundation Inc. (?Lender?), and Cyanotech Corporation, a Nevada Corporation (?Borrower?), dated as of April 12, 2021, is entered into as of December 14, 2022. Except as otherwise provided herein, all ca |
|
| December 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 14, 2022 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) |
|
| November 9, 2022 |
Press Release dated November 9, 2022 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023 KAILUA KONA, Hawaii (November 9, 2022) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2022 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANO |
|
| August 30, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 25, 2022 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 10, 2022 |
Press Release dated August 10, 2022 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal 2023 KAILUA KONA, Hawaii (August 10, 2022) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter |
|
| August 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2022 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH |
|
| July 18, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| June 22, 2022 |
Press Release dated June 22, 2022. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2022 KAILUA KONA, Hawaii (June 22, 2022) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth qu |
|
| June 22, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition period from to Commission File Number 0-14602 CYANOTECH CO |
|
| June 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2022 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 91- |
|
| June 22, 2022 |
Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the ?Agreement?) entered into between Matthew Custer (?Executive?), and Cyanotech Corporation (the ?Company?), will be effective upon execution by both parties. 1. Position; Commencement Date. Executive will be employed by the Company under this Agreement in the position of President and Chief Executive Officer. Execu |
|
| February 10, 2022 |
Press Release dated February 10, 2022. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022 KAILUA KONA, Hawaii (February 10, 2022) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial result |
|
| February 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2021 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOT |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 8, 2021 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) |
|
| November 10, 2021 |
Press Release dated November 10, 2021. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2022 KAILUA KONA, Hawaii (November 10, 2021) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial result |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2021 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANO |
|
| August 31, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 26, 2021 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2021 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH |
|
| August 11, 2021 |
Press Release dated August 11, 2021. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal 2022 KAILUA KONA, Hawaii (August 11, 2021) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter |
|
| July 15, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| June 22, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2021 Commission File Number 0-14602 CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada 91-1206026 (State or other jurisdiction of incorporation o |
|
| June 22, 2021 |
Press Release dated June 22, 2021. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2021 KAILUA KONA, Hawaii (June 22, 2021) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth qu |
|
| May 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 20, 2021 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 91-1 |
|
| April 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 12, 2021 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 91 |
|
| April 16, 2021 |
Exhibit 10.2 INTERCREDITOR AND SUBORDINATION AGREEMENT THIS INTERCREDITOR AND SUBORDINATION AGREEMENT (this ?Agreement?), is entered into as of April 12, 2021 (the ?Effective Date?), by and between FIRST FOUNDATION BANK, a California corporation (?Senior Creditor?), SKYWORDS FAMILY FOUNDATION INC. ( ?Subordinated Creditor?) and CYANOTECH CORPORATION, a Nevada corporation (?Cyanotech? or ?Borrower? |
|
| April 16, 2021 |
Exhibit 10.1 THIS NOTE IS SUBJECT TO THE TERMS OF THE INTERCREDITOR AND SUBORDINATION AGREEMENT, DATED AS OF APRIL 12, 2021, AMONG FIRST FOUNDATION BANK (THE ?SENIOR CREDITOR?) AND SKYWORDS FAMILY FOUNDATION INC. AND THE OTHER PARTIES THERETO, AS THE SAME MAY BE AMENDED, MODIFIED, RESTATED OR SUPPLEMENTED FROM TIME TO TIME (THE ?SUBORDINATION AGREEMENT?), TO THE EXTENT, AND IN THE MANNER PROVIDED |
|
| April 2, 2021 |
Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 19)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephon |
|
| March 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10) CYANOTECH CORP (Name of Issuer) COM PAR $0.02 (Title of Class of Securities) 232437301 (CUSIP Number) February 28, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| February 11, 2021 |
Press Release dated February 11, 2021. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021 KAILUA KONA, Hawaii (February 11, 2021) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the third qua |
|
| February 11, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2020 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOT |
|
| December 2, 2020 |
CYAN / Cyanotech Corp. / DAVIS MICHAEL A / - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6) Cyanotech Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 232437-301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane, Tiburon, California 94920 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Comm |
|
| December 2, 2020 |
Exhibit A Agreement of Joint Filing In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned, Michael A. |
|
| November 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2020 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANO |
|
| November 12, 2020 |
Press Release dated November 12, 2020. EX-99.1 5 ex211214.htm EXHIBIT 99.1 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2021 KAILUA KONA, Hawaii (November 12, 2020) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced |
|
| October 1, 2020 |
Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the “Agreement”) entered into between Felicia Ladin (“Executive”), and Cyanotech Corporation (the “Company”), will be effective upon execution by both parties of the date signed by Executive and Company below (the “Effective Date”). 1. Position; Commencement Date. Executive will be employed by the Company under this A |
|
| October 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 25, 2020 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commission File Number |
|
| October 1, 2020 |
Exhibit 10.1 SEPARATION AGREEMENT This Separation Agreement (the “Agreement”) is entered as of the Effective Date by and among Brian Orlopp (“Employee”) and Cyanotech Corporation, a Nevada corporation (the “Company”). 1. Separation of Employment. (a) Employee’s final date of employment with the Company will be September 25, 2020 (the “Separation Date”). By signing the Agreement below, Employee wil |
|
| August 31, 2020 |
Submission of Matters to a Vote of Security Holders - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 27, 2020 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 11, 2020 |
Press Release dated August 11, 2020. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal 2021 KAILUA KONA, Hawaii (August 11, 2020) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the first quarter of fiscal year 2021 |
|
| August 11, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2020 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH |
|
| July 15, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| June 23, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2020 Commission File Number 0-14602 CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada 91-1206026 (State or other jurisdiction of incorporation o |
|
| June 23, 2020 |
Press Release dated June 23, 2020. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2020 KAILUA KONA, Hawaii (June 23, 2020) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the fourth quarter and fiscal ye |
|
| May 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 5, 2020 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 91-12 |
|
| May 11, 2020 |
Promissory Note, dated April 30, 2020, by and between First Hawaiian Bank and Cyanotech Corporation. Exhibit 10.1 First Hawaiian NOTE SBA Loan # 69754672-07 SBA Loan Name CYANOTECH CORPORATION Date 04/30/2020 Loan Amount $1,380,975.00 Interest Rate One percent (1.00%) per year Borrower CYANOTECH CORPORATION Operating Company Lender First Hawaiian Bank, a Hawaii Corporation 1 PROMISE TO PAY: In return for the Loan, Borrower promises to pay to the order of Lender the amount of - One Million Three H |
|
| February 11, 2020 |
Press Release dated February 11, 2020. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020 KAILUA KONA, Hawaii (February 11, 2020) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the third qua |
|
| February 11, 2020 |
CYAN / Cyanotech Corp. 10-Q - Quarterly Report - FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2019 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOT |
|
| February 4, 2020 |
CYAN / Cyanotech Corp. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9) CYANOTECH CORP (Name of Issuer) COM PAR $0.02 (Title of Class of Securities) 232437301 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| November 12, 2019 |
Press Release dated November 12, 2019. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020 — Net sales increase 10.6% to $7,690,000, operating income was $409,000 for second quarter — KAILUA KONA, Hawaii (November 12, 2019) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-b |
|
| November 12, 2019 |
CYAN / Cyanotech Corp. 10-Q - Quarterly Report - FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2019 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANO |
|
| August 26, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 22, 2019 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 13, 2019 |
Press Release dated August 13, 2019. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal 2020 — Net sales increase 13% to $8,071,000, operating income was $49,000 — KAILUA KONA, Hawaii (August 13, 2019) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products |
|
| August 13, 2019 |
CYAN / Cyanotech Corp. 10-Q - Quarterly Report - FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2019 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH |
|
| July 10, 2019 |
CYAN / Cyanotech Corp. DEF 14A - - FORM DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| July 1, 2019 |
CYAN / Cyanotech Corp. 10-K - Annual Report - FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2019 Commission File Number 0-14602 CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada 91-1206026 (State or other jurisdiction of incorporation o |
|
| July 1, 2019 |
Press Release dated July 1, 2019. EX-99.1 6 ex148896.htm EXHIBIT 99.1 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2019 KAILUA KONA, Hawaii (July 1, 2019) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results f |
|
| June 7, 2019 |
SEPARATION AGREEMENT This Separation Agreement (the “Agreement”) is entered into as of the Effective Date by and among Mawae Rex Morton (“Executive”) and Cyanotech Corporation, a Nevada corporation (the “Company” or “Cyanotech”), with Morton and the Company together referred to herein as the “parties. |
|
| June 7, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2019 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| April 26, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2019 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 12, 2019 |
Exhibit 10.1 PROMISSORY NOTE This PROMISSORY NOTE (this “Note”) is entered into as of April 12, 2019, between Skywords Family Foundation Inc. (“Lender”), and Cyanotech Corporation, a Nevada corporation (“Borrower”). FOR VALUE RECEIVED, Borrower promises to pay to the order of Lender the principal amount of this Note together with interest at the rate stated hereunder. 1. Principal Amount. On the d |
|
| April 12, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2019 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 13, 2019 |
CYAN / Cyanotech Corp. / DAVIS MICHAEL A / - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5) Cyanotech Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 232437-301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane, Tiburon, California 94920 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Comm |
|
| March 13, 2019 |
Exhibit A Agreement of Joint Filing In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned, Michael A. |
|
| February 27, 2019 |
CYAN / Cyanotech Corp. / DAVIS MICHAEL A / - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4) Cyanotech Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 232437-301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane, Tiburon, California 94920 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Comm |
|
| February 13, 2019 |
Press Release dated February 13, 2019. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2019 — Net Sales Increase 9.8% to Record $10,044,000 — KAILUA KONA, Hawaii (February 13, 2019) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health |
|
| February 13, 2019 |
CYAN / Cyanotech Corp. FORM 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2018 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOT |
|
| January 22, 2019 |
CYAN / Cyanotech Corp. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8) CYANOTECH CORP (Name of Issuer) COM PAR $0.02 (Title of Class of Securities) 232437301 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| January 9, 2019 |
Exhibit 10.1 SEPARATION AGREEMENT This Separation Agreement (the “Agreement”) is entered as of the Effective Date by and among Jole Deal (“Employee”) and Cyanotech Corporation, a Nevada corporation (the “Company”). 1. Separation of Employment. Employee’s final date of employment with the Company will be on or before February 1, 2019 (the “Separation Date”). On that date, Employee will receive all |
|
| January 9, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2019 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| January 9, 2019 |
Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the “Agreement”) entered into between Brian Orlopp (“Executive”), and Cyanotech Corporation (the “Company”), will be effective upon execution by both parties of the date signed by Executive and Company below (the “Effective Date”). 1. Position; Commencement Date. Executive will be employed by the Company under this Ag |
|
| January 9, 2019 |
Cyanotech Names Brian Orlopp as VP Finance & Chief Financial Officer EX-99.1 4 ex132606.htm EXHIBIT 99.1 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Names Brian Orlopp as VP Finance & Chief Financial Officer KAILUA KONA, Hawaii (January 9, 2019) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced that Brian B. Orlopp has be |
|
| December 7, 2018 |
Exhibit 10.2 STATE OF HAWAII NATURAL ENERGY LABORATORY OF HAWAII AUTHORITY SUBLEASE NO. K-26 between NATURAL ENERGY LABORATORY OF HAWAII AUTHORITY in relation with the State Department of Business, Economic Development and Tourism and CELLANA LLC a Delaware corporation covering 6.216 acres of land at Keahole, North Kona, Hawaii • TABLE OF CONTENTS TERM OF SUBLEASE 2 RENTAL 2 1. Rental fees 2 2. Re |
|
| December 7, 2018 |
EX-10.1 2 ex131319.htm EXHIBIT 10.1 Exhibit 10.1 NATURAL ENERGY LABORATORY OF HAWAII AUTHORITY CELLANA LLC SUPPLEMENTAL AGREEMENT NO. 1 TO MODIFY SUBLEASE NO. K-26 DATED January 3rd, 2008 THIS SUPPLEMENTAL AGREEMENT NO. 1, made and entered into as of day of 2018, but effective as of October 1st, 2018, by and between the NATURAL ENERGY LABORATORY OF HAWAII AUTHORITY, STATE OF HAWAII, hereinafter re |
|
| December 7, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2018 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| November 13, 2018 |
CYAN / Cyanotech Corp. FORM 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2018 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANO |
|
| November 13, 2018 |
Press Release dated November 12, 2018. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2019 KAILUA KONA, Hawaii (November 12, 2018) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the seco |
|
| November 8, 2018 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SCHEDULE 13D/A Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 18)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephon |
|
| November 6, 2018 |
EX-10.1 2 ex128170.htm EXHIBIT 10.1 Exhibit 10.1 SEPARATION AGREEMENT This Separation Agreement (the “Agreement”) is entered as of the Effective Date by and among Gerard Watts (“Employee”) and Cyanotech Corporation, a Nevada corporation (the “Company”). 1. Separation of Employment. Employee’s final date of employment with the Company will be October 31, 2018 (the “Separation Date”). By signing the |
|
| November 6, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2018 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| November 6, 2018 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SCHEDULE 13D/A Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 17)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephon |
|
| October 31, 2018 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SCHEDULE 13D/A Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 16)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephon |
|
| October 29, 2018 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 15)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephon |
|
| October 19, 2018 |
CYAN / Cyanotech Corp. / DAVIS MICHAEL A / - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) Cyanotech Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 232437-301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane, Tiburon, California 94920 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Comm |
|
| September 7, 2018 |
Cyanotech® Corporation Signs Asset Purchase Agreement for Cellana’s Kona Demonstration Facility Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech® Corporation Signs Asset Purchase Agreement for Cellana’s Kona Demonstration Facility KAILUA-KONA, HAWAII (September 7, 2018) — Cyanotech® Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, is pleased to announce that it has signed a |
|
| September 7, 2018 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2018 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| August 28, 2018 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 27, 2018 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) 9 |
|
| August 13, 2018 |
Press Release dated August 13, 2018. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2019 KAILUA KONA, Hawaii (August 13, 2018) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the first quarter of fiscal year |
|
| August 13, 2018 |
CYAN / Cyanotech Corp. FORM 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2018 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH |
|
| July 9, 2018 |
CYAN / Cyanotech Corp. FORM DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| June 21, 2018 |
CYAN / Cyanotech Corp. FORM 10-K/A (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A AMENDMENT No. 1 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2018 Commission File Number 0-14602 CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada 91-1206026 (State or other jurisdiction |
|
| June 15, 2018 |
Press Release dated June 15, 2018 EX-99.1 6 ex116459.htm EXHIBIT 99.1 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 — FY2018 Sales Up 6.5%; EPS $0.18 vs. ($0.21) — KAILUA KONA, Hawaii (June 15, 2018) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition a |
|
| June 15, 2018 |
CYAN / Cyanotech Corp. FORM 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2018 Commission File Number 0-14602 CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada 91-1206026 (State or other jurisdiction of incorporation o |
|
| April 13, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2018 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| February 14, 2018 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 14)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephon |
|
| February 6, 2018 |
CYAN / Cyanotech Corp. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2017 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH CORPORATION (E |
|
| February 6, 2018 |
Press Release dated February 6, 2018. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Third Quarter of Fiscal Year 2018 — Sales up 20%; EPS $0.19 vs. ($0.06) — KAILUA KONA, Hawaii (February 6, 2018) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial res |
|
| January 29, 2018 |
CYAN / Cyanotech Corp. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7) CYANOTECH CORP (Name of Issuer) COM PAR $0.02 (Title of Class of Securities) 232437301 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| January 24, 2018 |
cyan201801238k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2018 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporat |
|
| January 24, 2018 |
Cyanotech Names Mawae Morton as Chief Executive Officer and a Member of the Board of Directors EX-99.1 3 ex103448.htm EXHIBIT 99.1 EXHIBIT 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Names Mawae Morton as Chief Executive Officer and a Member of the Board of Directors KAILUA KONA, HAWAII (January 24, 2018) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today anno |
|
| January 24, 2018 |
ex103447.htm Exhibit 10.1 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This First Amendment to Executive Employment (this ?January 2018 Amendment?) amends certain provisions of the Executive Employment Agreement entered into between Mawae Rex Morton (?Executive?) and Cyanotech Corporation (the ?Company?) on July 14, 2017 (the ?2017 Employment Agreement?), and will be effective as of the date |
|
| November 6, 2017 |
Press Release dated November 6, 2017. Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Second Quarter of Fiscal Year 2018 KAILUA KONA, Hawaii (November 6, 2017) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the second quarter and first s |
|
| November 6, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q cyan2017093010q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2017 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYA |
|
| August 29, 2017 |
LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS ex24.htm Exhibit 24 LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL MEN BY THESE PRESENTS: That I, MAWAE MORTON, hereby appoint each of Jol? E Deal, Dan Sprague and Jesse B. Debban as my attorneys in fact to: (1) execute for and on my behalf, in my capacity as an officer or director or both of Cyanotech Corporation (the ?Company?) and as a beneficial owner of securities of |
|
| August 25, 2017 |
Submission of Matters to a Vote of Security Holders cyan201708258k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 24, 2017 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commis |
|
| August 10, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2017 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH CORPORATION (Exact |
|
| August 10, 2017 |
Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for First Quarter of Fiscal Year 2018 — Sales increase 20%, EPS $0.09 vs ($0.12) — KAILUA KONA, Hawaii (August 10, 2017) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial res |
|
| August 1, 2017 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SCHEDULE 13D/A Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 13)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephon |
|
| July 17, 2017 |
ex10-1.htm Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the ?Agreement?) entered into between Mawae Rex Morton (?Executive?), and Cyanotech Corporation (the ?Company?), will be effective upon execution by both parties. 1. Position; Commencement Date. Executive will be employed by the Company under this Agreement in the position of President. Executive will comme |
|
| July 17, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2017 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| July 17, 2017 |
Cyanotech Names Mawae Morton President ex99-1.htm Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Names Mawae Morton President KAILUA KONA, Hawaii (July 17, 2017) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN) today announced that the Board of Directors has named Mawae Morton as President effective immediately. Mr. Morton will report directly to the Company?s Chief Executive Offic |
|
| July 7, 2017 |
cyan20170630def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Ru |
|
| June 22, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2017 Commission File Number 0-14602 CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada 91-1206026 (State or other jurisdiction of incorporation or organization) (I |
|
| June 22, 2017 |
Cyanotech Reports Financial Results for Fourth Quarter and Fiscal Year 2017 EX-99.1 6 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for Fourth Quarter and Fiscal Year 2017 KAILUA KONA, Hawaii (June 22, 2017) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for th |
|
| April 11, 2017 |
Entry into a Material Definitive Agreement, Other Events cyan201704118k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2017 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation |
|
| April 11, 2017 |
Exhibit 10.1 SETTLEMENT AGREEMENT This SETTLEMENT AGREEMENT (the ?Settlement Agreement? or the ?Agreement?) is effective as of April 6, 2017 (the ?Effective Date?), and is made by, between and among, Brent Bailey (?Bailey?), on the one hand, and Cyanotech Corporation (?Cyanotech?) (hereinafter, Bailey and Cyanotech are referred to collectively as the ?Parties?), as follows: R E C I T A LS WHEREAS, |
|
| March 17, 2017 |
CYAN / Cyanotech Corp. / DAVIS MICHAEL A / Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Cyanotech Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 232437-301 (CUSIP Number) Michael A. Davis 1621 Juanita Lane, Tiburon, California 94920 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Comm |
|
| March 15, 2017 |
cyan201703148k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2017 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporatio |
|
| March 15, 2017 |
ex10-1.htm Exhibit 10.1 INDEMNIFICATION AGREEMENT This Indemnification Agreement (this ?Agreement?), effective as of [date of agreement] (the ?Effective Date?), by and between Cyanotech Corporation, a Nevada corporation (the ?Company?), and [name of director or officer] (the ?Indemnitee?). RECITALS A. It is reasonable, prudent and in the best interests of the Company and its stockholders for the C |
|
| February 16, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2017 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| February 15, 2017 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SC 13 D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 12)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of P |
|
| February 7, 2017 |
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2017 ex99-1.htm Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2017 KAILUA KONA, Hawaii (February 7, 2017) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results fo |
|
| February 7, 2017 |
Cyanotech FORM 10-Q (Quarterly Report) cyan2016123110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2016 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYAN |
|
| January 23, 2017 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 11)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of P |
|
| January 19, 2017 |
Cyanotech SC 13D/A (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 10)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of P |
|
| January 17, 2017 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Pe |
|
| January 9, 2017 |
CYAN / Cyanotech Corp. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6) CYANOTECH CORP (Name of Issuer) Common (Title of Class of Securities) 232437301 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil |
|
| December 20, 2016 |
CYAN / Cyanotech Corp. / DAVIS MICHAEL A / Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Cyanotech Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 232437-301 (CUSIP Number) Michael Davis 1621 Juanita Lane, Tiburon, California 94920 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communi |
|
| December 16, 2016 |
Cyanotech FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 15, 2016 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commission File Number) |
|
| November 10, 2016 |
cyan20161108s8.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada 91-1206026 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 73-4460 Queen Kaahumanu Highway, Suite 102 Kailua-Ko |
|
| November 10, 2016 |
cyan2016090110q.htm Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2017 ? Net sales increase 16% to a record $9.9 million, EPS $0.02 vs. $0.00 ? KAILUA KONA, Hawaii (November 10, 2016) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microal |
|
| November 10, 2016 |
Cyanotech FORM 10-Q (Quarterly Report) cyan2016090110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2016 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYA |
|
| November 4, 2016 |
cyan20161028def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Ru |
|
| October 31, 2016 |
LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS poa.htm Exhibit 24 LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL MEN BY THESE PRESENTS: That I, NANCY E. KATZ, hereby appoint each of Jolé E Deal, Dan Sprague and Jesse B. Debban as my attorneys in fact to: (1) execute for and on my behalf, in my capacity as an officer or director or both of Cyanotech Corporation (the “Company”) and as a beneficial owner of securities of |
|
| October 25, 2016 |
Cyanotech Names Nancy Katz as a Director ex99-1.htm Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Names Nancy Katz as a Director KAILUA KONA, Hawaii (October 25, 2016) ? The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Nancy Katz as a Director of the Company effective October 21, 2016. ?We are pleased to welcome Ms. Katz to Cyanotech?s Board,? said |
|
| October 25, 2016 |
Cyanotech FORM 8-K (Current Report/Significant Event) cyan201610248k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2016 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporat |
|
| October 18, 2016 |
Cyanotech SC 13D (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Pe |
|
| October 6, 2016 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Pe |
|
| September 21, 2016 |
CYAN / Cyanotech Corp. / DAVIS MICHAEL A / Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Cyanotech Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 232437-301 (CUSIP Number) Michael Davis 1621 Juanita Lane, Tiburon, California 94920 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communic |
|
| September 9, 2016 |
Cyanotech FORM 8-K (Current Report/Significant Event) cyan201609088k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2016 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorpora |
|
| September 1, 2016 |
Cyanotech FORM 8-K (Current Report/Significant Event) cyan201608318k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 30, 2016 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA 000-14602 91-1206026 (State or other jurisdiction of (Commission |
|
| September 1, 2016 |
ex4-1.htm Exhibit 10.1 FIRST FOUNDATION BANK Date: June 3, 2016 REVOLVING CREDIT AGREEMENT FIRST FOUNDATION BANK, a California corporation ("Bank"), makes this Agreement ("Agreement") to make loans (individually "Loan" and collectively "Loans") to CYANOTECH CORPORATION, a Nevada corporation, whose mailing address is 73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, Hawaii 96740 (the "Borrow |
|
| August 26, 2016 |
Submission of Matters to a Vote of Security Holders cyan201608268k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 25, 2016 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commis |
|
| August 26, 2016 |
Submission of Matters to a Vote of Security Holders cyan201608268k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 25, 2016 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commis |
|
| August 23, 2016 |
LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS mulderpoa.htm Exhibit 24 LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL MEN BY THESE PRESENTS: That I, DAVID M. MULDER, hereby appoint each of Jol? E Deal, Dan Sprague and Jesse B. Debban as my attorneys in fact to: (1) execute for and on my behalf, in my capacity as an officer or director or both of Cyanotech Corporation (the ?Company?) and as a beneficial owner of securi |
|
| August 23, 2016 |
LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS mulderpoa.htm Exhibit 24 LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL MEN BY THESE PRESENTS: That I, DAVID M. MULDER, hereby appoint each of Jol? E Deal, Dan Sprague and Jesse B. Debban as my attorneys in fact to: (1) execute for and on my behalf, in my capacity as an officer or director or both of Cyanotech Corporation (the ?Company?) and as a beneficial owner of securi |
|
| August 17, 2016 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Pe |
|
| August 15, 2016 |
Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2017 EX-99.1 5 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2017 KAILUA KONA, Hawaii (August 15, 2016) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial resu |
|
| August 15, 2016 |
Cyanotech FORM 10-Q (Quarterly Report) cyan2016070810q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2016 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTEC |
|
| August 15, 2016 |
Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2017 EX-99.1 5 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2017 KAILUA KONA, Hawaii (August 15, 2016) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial resu |
|
| August 15, 2016 |
Cyanotech FORM 10-Q (Quarterly Report) cyan2016070810q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2016 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTEC |
|
| August 9, 2016 |
CYAN / Cyanotech Corp. / Meridian OHC Partners, LP - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Pe |
|
| July 26, 2016 |
Cyanotech SC 13D/A (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Pe |
|
| July 15, 2016 |
cyan20160712def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Ru |
|
| June 23, 2016 |
Cyanotech FORM 10-K (Annual Report) cyan2016033110k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2016 Commission File Number 0-14602 CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada 91-1206026 (State or other jurisdiction of incorporation |
|
| June 23, 2016 |
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 ex99-1.htm Exhibit 99.1 News Release 6 Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 KAILUA KONA, Hawaii (June 23, 2016) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth qu |
|
| June 8, 2016 |
cyan201606078k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2016 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) |
|
| May 25, 2016 |
Cyanotech SC 13 D/A (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Pe |
|
| May 23, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2016 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| May 23, 2016 |
Cyanotech Names David Mulder as a Director cyan201605198k.htm Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Names David Mulder as a Director KAILUA KONA, Hawaii (May 23, 2016) ? The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN) named David Mulder as a Director of the Company effective May 17, 2016. He replaces Ralph Carlton, who resigned. ?With his broad and var |
|
| May 19, 2016 |
Cyanotech SC 13D/A (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Pe |
|
| May 10, 2016 |
CYAN / Cyanotech Corp. / Bailey Brent David - SCHEDULE 13D/A Activist Investment bail20160509sc13da.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 1) INFORMATION TO BE IN INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) CYANOTECH CORPORATION (Name of Issuer) COMMON STOCK, PAR VALUE $0.02 PER SHARE (Title of Class of Securities) 232437301 (CUSIP Number) Jolé D |
|
| May 10, 2016 |
Cyanotech SCHEDULE 13D/A (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 2) INFORMATION TO BE IN INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) CYANOTECH CORPORATION (Name of Issuer) COMMON STOCK, PAR VALUE $0.02 PER SHARE (Title of Class of Securities) 232437301 (CUSIP Number) Jol? Deal, Vice President-Fin |
|
| May 10, 2016 |
Cyanotech SC 13D/A (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Pe |
|
| May 9, 2016 |
Cyanotech SC 13D (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06840 (Name, Address and Telephone Number of Per |
|
| April 12, 2016 |
Cyanotech FORM 8-K (Current Report/Significant Event) cyan201604118k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 12, 2016 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commiss |
|
| April 4, 2016 |
SEPARATION AGREEMENT AND RELEASE OF CLAIMS ex10-1.htm EXHIBIT 10.1 SEPARATION AGREEMENT AND RELEASE OF CLAIMS This Separation Agreement and Release of Claims (this ?Agreement?) is made and entered into as of March 31, 2016 (the ?Separation Date?) by and between Brent D. Bailey (?Bailey?) and Cyanotech Corporation, a Nevada corporation, and its affiliated entities (collectively ?Cyanotech? or the ?Company?), with Bailey and the Company toge |
|
| April 4, 2016 |
Founder Gerry Cysewski, Ph.D., Named Interim President & CEO of Cyanotech ex99-1.htm EXHIBIT 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Founder Gerry Cysewski, Ph.D., Named Interim President & CEO of Cyanotech KAILUA KONA, HAWAII (April 4, 2016) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced that its founder, Gerald R. Cysewski, Ph.D. |
|
| April 4, 2016 |
Cyanotech FORM 8-K (Current Report/Significant Event) cyan201604018k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2016 Cyanotech Corporation (Exact name of Registrant as specified in its charter) Nevada 000-14602 91-1206026 (State or Other Jurisdiction of Incorporatio |
|
| February 12, 2016 |
Cyanotech SCHEDULE 13 G (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Cyanotech Corporation (Name of Issuer) Common Stock, par value $0.02 per share (Title of Class of Securities) 232437-301 (CUSIP Number) Scott A Shuda Meridian OHC Partners, LP 425 Weed Street New Canaan, CT 06480 (Name, Address and Telephone Number of Pe |
|
| February 11, 2016 |
CYAN / Cyanotech Corp. 10-Q - Quarterly Report - FORM 10-Q cyan2015123110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended December 31, 2015 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYAN |
|
| February 11, 2016 |
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2016 ex99-1.htm Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2016 KAILUA KONA, Hawaii (February 11, 2016) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial res |
|
| February 8, 2016 |
CYAN / Cyanotech Corp. / DAVIS MICHAEL A / - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 9)* Cyanotech Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 232437- |
|
| January 27, 2016 |
CYAN / Cyanotech Corp. / WELLS FARGO & COMPANY/MN Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5) CYANOTECH CORP (Name of Issuer) COM PAR $0.02 (Title of Class of Securities) 232437301 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| November 12, 2015 |
HAZARDOUS SUBSTANCES CERTIFICATE AND INDEMNITY AGREEMENT EX-4.8 9 ex4-8.htm EXHIBIT 4.8 Exhibit 4.8 HAZARDOUS SUBSTANCES CERTIFICATE AND INDEMNITY AGREEMENT THIS CERTIFICATE AND INDEMNITY is made in connection with and as partial consideration for the making of a loan in the principal amount of $2,500,000.00 (the "Loan") by FIRST FOUNDATION BANK, a California corporation ("Lender"), to CYANOTECH CORPORATION, a Nevada corporation, and NUTREX HAWAII, INC. |
|
| November 12, 2015 |
Exhibit 4.1 TERM LOAN AGREEMENT THIS AGREEMENT, is made on July 30, 2015, by and between FIRST FOUNDATION BANK, a California corporation, whose mailing address is 18101 Von Karman Avenue, Suite 750, Irvine, California 92612 (the "Lender"), and CYANOTECH CORPORATION, a Nevada corporation, and NUTREX HAWAII, INC., a Hawaii corporation, both of whose mailing address is 73-4460 Queen Kaahumanu Highway |
|
| November 12, 2015 |
Exhibit 4.6 SECURITY AGREEMENT THIS SECURITY AGREEMENT ("Security Agreement") made on July 30, 2015 by and between NUTREX HAWAII, INC., a Hawaii corporation, whose mailing address is 73-4460 Queen Kaahumanu Highway, Suite I 02, Kailua-Kona, Hawaii 96740 (hereafter called the "Debtor"), and FIRST FOUNDATION BANK, a California corporation, whose mailing address is 18101 Von Karman Avenue, Suite 750, |
|
| November 12, 2015 |
Exhibit 4.2 PROMISSORY NOTE Loan No. 22000167 U.S. $2,500,000.00 Honolulu, Hawaii Dated: July 30, 2015 FOR VALUE RECEIVED, the undersigned, CYANOTECH CORPORATION, a Nevada corporation, and NUTREX HAWAII, INC., a Hawaii corporation (individually and collectively, "Borrower"), promise to pay FIRST FOUNDATION BANK, a California corporation ("Bank") or order, the principal sum of TWO MILLION FIVE HUND |
|
| November 12, 2015 |
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2016 Exhibit 99.1 News Release Contact: Bruce Russell (310) 346-6131 [email protected] Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2016 KAILUA KONA, Hawaii (November 12, 2015) ? Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for th |
|
| November 12, 2015 |
UNITED STATES DEPARTMENT OF AGRICULTURE Exhibit 4.7 Form 4279-3 UNITED STATES DEPARTMENT OF AGRICULTURE FORM APPROVED (Rev. 07-05) RURAL DEVELOPMENT OMB NO. 0570-0017 CONDITIONAL COMMITMENT (Business and Industry and Section 9006 Program) TO: Lender Case No. PACIFIC RIM BANK 61-005-600267157 Lender's Address State TWO WATERFRONT PLAZA 500 ALA MOANA BLVD., #2A HAWAII HONOLULU HI 96813-4920 Borrower Principal Amount of Loan CYANOTECH CORP |
|
| November 12, 2015 |
Exhibit 4.5 SECURITY AGREEMENT THIS SECURITY AGREEMENT ("Security Agreement") made on July 30, 2015 by and between CYANOTECH CORPORATION, a Nevada corporation, whose mailing address is 73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kana, Hawaii 96740 (hereafter called the "Debtor"), and FIRST FOUNDATION BANK, a California corporation, whose mailing address is 18101 Von Karman Avenue, Suite 750 |
|
| November 12, 2015 |
Exhibit 4.9 LAND COURT SYSTEM REGULAR SYSTEM After Recordation, Return by Mail D Pick-up D Phone#: Document Contains 11 Pages Tax Map Key No. (3) 7-3-043-063 SUBLESSOR'S CONSENT TO MORTGAGE OF SUBLEASE K-4; ESTOPPEL CERTIFICATE AND SUBORDINATION AGREEMENT I. CONSENT. The NATURAL ENERGY LABORATORY OF HAWAII AUTHORITY, STATE OF HAWAII (the "Sublessor"), the (i) lessee under that certain unrecorded G |
|
| November 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended September 30, 2015 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH CORPORATION ( |
|
| November 12, 2015 |
Exhibit 4.3 LAND COURT SYSTEM REGULAR SYSTEM AFI'ER RECORDATION, RETURN BY MAIT.... ( ) PICKUP ( ) Total No. of Pages: 28 Tax Map Key No. (3) 7-3-043-063 MORTGAGE, SECURITY AGREEMENT AND FINANCING STATEMENT MORTGAGOR: CYANOTECH CORPORATION, a Nevada corporation, whose mailing address is 73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, Hawaii 96740 MORTGAGEE: FIRST FOUNDATION BANK, a Califo |
|
| November 12, 2015 |
EX-4.4 5 ex4-4.htm EXHIBIT 4.4 Exhibit 4.4 LAND COURT SYSTEM REGULAR SYSTEM AFTER RECORDATION, RETURN BY MAIL ( ) PICKUP ( ) Total No. of Pages: 16 Tax Map Key No. (3) 7-3-043-063 ASSIGNMENT OF LESSOR'S INTEREST IN LEASES AND RENTS ASSIGNOR: CYANOTECH CORPORATION, a Nevada corporation, whose mailing address is 73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, Hawaii 96740 ASSIGNEE: FIRST FO |
|
| October 19, 2015 |
Cyanotech FORM 8-K (Current Report/Significant Event) cyan201510168k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 15, 2015 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-14602 (Commi |
|
| September 2, 2015 |
cyan20150828def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Ru |
|
| August 27, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A AMENDMENT No. 1 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2015 Commission File Number 0-14602 CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada 91-1206026 (State or other jurisdiction of incorporation o |
|
| August 26, 2015 |
Entry into a Material Definitive Agreement cyan201508258k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 20, 2015 Date of Report: (Date of earliest event reported) Cyanotech Corporation (Exact name of registrant as specified in its charter) NEVADA 000-14602 91-1206026 (State or other jurisdiction of (Commission |
|
| August 7, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For Quarterly Period Ended June 30, 2015 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From to Commission File Number 0-14602 CYANOTECH CORPORATION (Exact |
